CY1107107T1 - SULFONAMID PRODUCTS FOR DISEASE DISEASE - Google Patents

SULFONAMID PRODUCTS FOR DISEASE DISEASE

Info

Publication number
CY1107107T1
CY1107107T1 CY20071101628T CY071101628T CY1107107T1 CY 1107107 T1 CY1107107 T1 CY 1107107T1 CY 20071101628 T CY20071101628 T CY 20071101628T CY 071101628 T CY071101628 T CY 071101628T CY 1107107 T1 CY1107107 T1 CY 1107107T1
Authority
CY
Cyprus
Prior art keywords
disease
sulfonamid
products
disorders
conditions
Prior art date
Application number
CY20071101628T
Other languages
Greek (el)
Inventor
Alan D Brown
Mark E Bunnage
Paul A Glossop
Kim James
Charlotte Al Lane
Russell A Lewthwaite
Ian B Moses
David A Price
Nicholas M Thomson
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34890770&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1107107(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0406387A external-priority patent/GB0406387D0/en
Priority claimed from EP05702252A external-priority patent/EP1708991B1/en
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of CY1107107T1 publication Critical patent/CY1107107T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring

Abstract

Η εφεύρεση αναφέρεται σε ενώσεις του τύπου (1) και διεργασίες για την παραγωγή τους, συνθέσεις που τις περιέχουν και χρήσεις τέτοιων παραγώγων. Οι ενώσεις σύμφωνα με την παρούσα εφεύρεση είναι χρήσιμες για πολλές νόσους, διαταραχές και καταστάσεις, και ιδιαίτερα, φλεγμονώδεις, αλλεργικές και αναπνευστικές νόσους, διαταραχές και καταστάσεις.The invention relates to compounds of formula (1) and processes for their production, compositions containing them, and uses of such derivatives. The compounds according to the present invention are useful for many diseases, disorders and conditions, and in particular, inflammatory, allergic and respiratory diseases, disorders and conditions.

CY20071101628T 2004-01-22 2007-12-20 SULFONAMID PRODUCTS FOR DISEASE DISEASE CY1107107T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP04290169 2004-01-22
GB0406387A GB0406387D0 (en) 2004-03-22 2004-03-22 Sulfonamide derivatives for the treatment of diseases
US60026004P 2004-08-09 2004-08-09
EP05702252A EP1708991B1 (en) 2004-01-22 2005-01-12 Sulfonamide derivatives for the treatment of diseases

Publications (1)

Publication Number Publication Date
CY1107107T1 true CY1107107T1 (en) 2012-10-24

Family

ID=34890770

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071101628T CY1107107T1 (en) 2004-01-22 2007-12-20 SULFONAMID PRODUCTS FOR DISEASE DISEASE

Country Status (7)

Country Link
CR (1) CR9838A (en)
CY (1) CY1107107T1 (en)
EC (1) ECSP066700A (en)
HK (1) HK1096379A1 (en)
HR (1) HRP20070542T3 (en)
IL (1) IL176564A (en)
MA (1) MA28302A1 (en)

Also Published As

Publication number Publication date
HK1096379A1 (en) 2007-06-01
ECSP066700A (en) 2006-10-31
IL176564A0 (en) 2006-10-31
HRP20070542T3 (en) 2008-02-29
CR9838A (en) 2008-04-21
MA28302A1 (en) 2006-11-01
IL176564A (en) 2011-11-30

Similar Documents

Publication Publication Date Title
CY1106894T1 (en) Sulfonamide derivatives for the treatment of diseases
CY1110735T1 (en) 3- Ή 4-SINGLE-ESTABLISHED PHENOL AND THIOPHANOL PRODUCERS USEFUL FOR H3 PROJECTS
EA200870282A1 (en) AMINE DERIVATIVES
EA200601462A1 (en) CONNECTIONS FOR THE TREATMENT OF DISEASES
CY1113105T1 (en) XANTHINIS PRODUCTS, THEIR PRODUCTION AND USE OF THEM AS MEDICINES
EA200601223A1 (en) DERIVATIVES OF SULFONAMIDE FOR THE TREATMENT OF DISEASES
BRPI0408369A (en) indole derivatives useful for treating disease
CR8649A (en) FORMAMIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES
CY1111757T1 (en) XANTHINI PRODUCTS AS ELECTRIC SUSPENSIONS HM74A
TW200505862A (en) 2-amino-pyridine derivatives useful for the treatment of diseases
CY1111166T1 (en) NEW PRODUCTS OF 1,4-BENZOTHYTHEPEINO-1,1-DIOXIDE SUBSTITUTED BY BENZYL ROOTS, PROCESSING METHODS FOR PRESENTATION
ECSP056164A (en) USEFUL COMPOUNDS FOR THE TREATMENT OF DISEASES
UY28339A1 (en) USED 2-AMINO-PYRIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES
CY1107596T1 (en) TETRAHYDRONALPHALINE PRODUCTS, METHOD FOR PRODUCING THESE AND USE AS ANTI-FLY
NO20051406L (en) Indole derivatives as beta-2 agonists
CY1113617T1 (en) New Phenylaminopyrimidine Derivatives as Inhibitors of Kinase BCR-ABL
SE0303180D0 (en) Novel compounds
CY1109854T1 (en) AZADICYLIC PRODUCTS (3.1.0) EXCELLENT USEFUL AS D3 DOPAMIN RECEPTOR REGULATORS
SE0302232D0 (en) Novel Compounds
CY1108752T1 (en) PURINIS PRODUCERS ACTING AS A2A-RECEPTOR AGONS
CY1107429T1 (en) Substituted N-cyclohexylimidazolinones with modifying action on MCH
CY1113257T1 (en) Benzylopiperazine derivatives which are useful in the treatment of gastrointestinal disorders
ATE347555T1 (en) 6-AMINOMORPHINAND DERIVATIVES, PRODUCTION PROCESS THEREOF AND THEIR USE
BRPI0508927A (en) compounds useful for treating diseases
CY1107107T1 (en) SULFONAMID PRODUCTS FOR DISEASE DISEASE